Research output per year
Research output per year
Research output
- 30 results
Search results
-
2024
Factors for a broad technology assessment of comprehensive genomic profiling in advanced cancer, a systematic review
van Schaik, L. F., Engelhardt, E. G., Wilthagen, E. A., Steeghs, N., Coves, A. F., Joore, M. A., van Harten, W. H. & Retel, V. P., 1 Oct 2024, In: Critical Reviews in Oncology/Hematology. 202, 15 p., 104441.Research output: Contribution to journal › (Systematic) Review article › peer-review
-
How health technology assessment can help to address challenges in drug repurposing: a conceptual framework
Abu-Zahra, T., Grimm, S. E., Scholte, M., Raymakers, A. J. N., Kesselheim, A. S. & Joore, M., 1 Jun 2024, In: Drug Discovery Today. 29, 6, 8 p., 104008.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Software with artificial intelligence-derived algorithms for analysing CT brain scans in people with a suspected acute stroke: a systematic review and cost-effectiveness analysis
Westwood, M., Ramaekers, B., Grimm, S., Armstrong, N., Wijnen, B., Ahmadu, C., de Kock, S., Noake, C. & Joore, M., 1 Mar 2024, In: Health Technology Assessment. 28, 11, p. 1-204 204 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
2023
Comprehensive Review of Methods to Assess Uncertainty in Health Economic Evaluations
Otten, T. M., Grimm, S. E., Ramaekers, B. & Joore, M. A., Jun 2023, In: Pharmacoeconomics. 41, 6, p. 619-632 14 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Fenfluramine for Treating Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Wijnen, B., Witlox, W., Wolff, R., Fayter, D., Ramaekers, B., Otten, T., Ryder, S., Posadzki, P., Worthy, G., Stirk, L., Armstrong, N., Kleijnen, J. & Joore, M., Jan 2023, In: Pharmacoeconomics. 41, 1, p. 33-42 10 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
van Asselt, A. D. I., Armstrong, N., Kimman, M., Peeters, A., McDermott, K., Stirk, L., Ahmadu, C., Govers, T. M., Hoentjen, F., Joore, M. A. & Grimm, S. E., Mar 2023, In: Pharmacoeconomics. 41, 3, p. 239-251 13 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Headroom Analysis for Early Economic Evaluation: A Systematic Review
Boudewijns, E. A., Otten, T. M., Gobianidze, M., Ramaekers, B. L., van Schayck, O. C. P. & Joore, M. A., Mar 2023, In: Applied Health Economics and Health Policy. 21, 2, p. 195-204 10 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open AccessFile299 Downloads (Pure) -
Oral Azacitidine for Maintenance Treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Witlox, W., Grimm, S., Howick, J., Armstrong, N., Ahmadu, C., McDermott, K., Otten, T., Noake, C., Wolff, R. & Joore, M., Aug 2023, In: Pharmacoeconomics. 41, 8, p. 857-867 11 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
2022
Belimumab for Treating Active Autoantibody-Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Otten, T., Riemsma, R., Wijnen, B., Armstrong, N., Stirk, L., Gordon, C., Ramaekers, B., Kleijnen, J., Joore, M. & Grimm, S., 1 Sept 2022, In: Pharmacoeconomics. 40, 9, p. 851-861 11 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Grimm, S. E., Witlox, W., Wolff, R., Chalker, A., Hiligsmann, M., Wijnen, B., Ahmadu, C., Ryder, S., Armstrong, N., Duffy, S., Syndikus, I., Kleijnen, J. & Joore, M. A., May 2022, In: Pharmacoeconomics. 40, 5, p. 509-518 10 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
The effectiveness of health education interventions on cervical cancer prevention in Africa: A systematic review
Makadzange, E. E., Peeters, A., Joore, M. A. & Kimman, M. L., Nov 2022, In: Preventive Medicine. 164, p. 107219 12 p., 107219.Research output: Contribution to journal › (Systematic) Review article › peer-review
-
2021
Early technology assessment of using whole genome sequencing in personalized oncology
Simons, M., van de Ven, M., Coupé, V., Joore, M., IJzerman, M., Koffijberg, E., Frederix, G., Uyl-De Groot, C., Cuppen, E., van Harten, W. & Retèl, V., 3 Jun 2021, In: Expert Review of Pharmacoeconomics & Outcomes Research. 21, 3, p. 343-351 9 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Filgotinib for Moderate to Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Grimm, S. E., Wijnen, B., Riemsma, R., Fayter, D., Armstrong, N., Ahmadu, C., Brandts, L., Misso, K., Kirwan, J. R., Kleijnen, J. & Joore, M. A., Dec 2021, In: Pharmacoeconomics. 39, 12, p. 1397-1410 14 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation
Westwood, M., Ramaekers, B., Grimm, S., Worthy, G., Fayter, D., Armstrong, N., Buksnys, T., Ross, J., Joore, M. & Kleijnen, J., May 2021, In: Health Technology Assessment. 25, 33, p. 1-276 277 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Witlox, W. J. A., Grimm, S. E., Riemsma, R., Armstrong, N., Ryder, S., Duffy, S., Carrera, V. H., Posadzki, P., Worthy, G., Pouwels, X. G. L. V., Ramaekers, B. L. T., Kleijnen, J., Joore, M. A. & van Asselt, A. D. I., Feb 2021, In: Pharmacoeconomics. 39, 2, p. 171-180 10 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
New Frontiers for Fairer Breast Cancer Care in a Globalized World
Verhoeven, D., Allemani, C., Kaufman, C., Siesling, S., Joore, M., Brain, E. & Costa, M. M., Apr 2021, In: European Journal of Breast Health. 17, 2, p. 86-94 9 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
2020
Cannabidiol for Adjuvant Treatment of Seizures Associated with Lennox-Gastaut Syndrome and Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Wijnen, B., Armstrong, N., Ramaekers, B., Witlox, W., Westwood, M., Fayter, D., Ryder, S., Buksnys, T., Worthy, G., Misso, K., Grimm, S., Kleijnen, J. & Joore, M., Oct 2020, In: Pharmacoeconomics. 38, 10, p. 1043-1053 11 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Durvalumab for the Treatment of Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Witlox, W. J. A., van Asselt, A. D. I., Wolff, R., Armstrong, N., Worthy, G., Chalker, A., Buksnys, T., Stirk, L., Kleijnen, J., Joore, M. A. & Grimm, S. E., Apr 2020, In: Pharmacoeconomics. 38, 4, p. 317-324 8 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Pouwels, X. G. L. V., Petersohn, S., Carrera, V. H., Denniston, A. K., Chalker, A., Raatz, H., Armstrong, N., Shah, D., Witlox, W., Worthy, G., Noake, C., Riemsma, R., Kleijnen, J. & Joore, M. A., May 2020, In: Pharmacoeconomics. 38, 5, p. 431-441 11 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Observed versus modelled lifetime overall survival of targeted therapies and immunotherapies for advanced non-small cell lung cancer patients - A systematic review
Simons, M., Ramaekers, B., Peeters, A., Mankor, J., Paats, M., Aerts, J., van Harten, W., Retel, V. & Joore, M., Sept 2020, In: Critical Reviews in Oncology/Hematology. 153, 12 p., 103035.Research output: Contribution to journal › (Systematic) Review article › peer-review
-
2019
Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Ramaekers, B. L. T., Riemsma, R., Grimm, S., Fayter, D., Deshpande, S., Armstrong, N., Witlox, W., Pouwels, X., Duffy, S., Worthy, G., Kleijnen, J. & Joore, M. A., Jul 2019, In: Pharmacoeconomics. 37, 7, p. 887-894 8 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Grimm, S. E., Armstrong, N., Ramaekers, B. L. T., Pouwels, X., Lang, S., Petersohn, S., Riemsma, R., Worthy, G., Stirk, L., Ross, J., Kleijnen, J. & Joore, M. A., May 2019, In: Pharmacoeconomics. 37, 5, p. 655-667 13 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Grimm, S. E., Fayter, D., Ramaekers, B. L. T., Petersohn, S., Riemsma, R., Armstrong, N., Pouwels, X., Witlox, W., Noake, C., Worthy, G., Kleijnen, J. & Joore, M. A., Oct 2019, In: Pharmacoeconomics. 37, 10, p. 1195-1207 13 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
2018
A systematic review on economic evaluations of school-based lifestyle interventions targeting weight-related behaviours among 4-12 year olds: Issues and ways forward
Oosterhoff, M., Bosma, H., van Schayck, O. C. P., Evers, S. M. A. A., Dirksen, C. D. & Joore, M. A., 1 Sept 2018, In: Preventive Medicine. 114, p. 115-122 8 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Ramaekers, B. L. T., Wolff, R. F., Pouwels, X., Oosterhoff, M., Van Giessen, A., Worthy, G., Noake, C., Armstrong, N., Kleijnen, J. & Joore, M. A., 1 Aug 2018, In: Pharmacoeconomics. 36, 8, p. 917-927 11 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis
Westwood, M., Ramaekers, B., Lang, S., Grimm, S., Deshpande, S., de Kock, S., Armstrong, N., Joore, M. & Kleijnen, J., 1 Aug 2018, In: Health Technology Assessment. 22, 44, p. 1-266 266 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Ticagrelor for Secondary Prevention of Atherothrombotic Events After Myocardial Infarction: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Pouwels, X. G. L. V., Wolff, R., Ramaekers, B. L. T., Van Giessen, A., Lang, S., Ryder, S., Worthy, G., Duffy, S., Armstrong, N., Kleijnen, J. & Joore, M. A., 1 May 2018, In: Pharmacoeconomics. 36, 5, p. 533-543 11 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Trifluridine-Tipiracil for Previously Treated Metastatic Colorectal Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Ramaekers, B. L. T., Wolff, R., van Giessen, A., Pouwels, X., Fayter, D., Lang, S., Armstrong, N., Worthy, G., Duffy, S., Kleijnen, J. & Joore, M. A., 1 Mar 2018, In: Pharmacoeconomics. 36, 3, p. 285-288 4 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
2017
Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal
Ramaekers, B. L. T., Riemsma, R., Tomini, F., van Asselt, T., Deshpande, S., Duffy, S., Armstrong, N., Severens, J. L., Kleijnen, J. & Joore, M. A., Feb 2017, In: Pharmacoeconomics. 35, 2, p. 191-202 12 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancer
Pouwels, X. G. L. V., Ramaekers, B. L. T. & Joore, M. A., Oct 2017, In: Breast Cancer Research and Treatment. 165, 3, p. 485-498 14 p.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access